Exor Capital LLP Teva Pharmaceutical Industries LTD Transaction History
Exor Capital LLP
- $2.78 Billion
- Q2 2024
A detailed history of Exor Capital LLP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Exor Capital LLP holds 26,462,600 shares of TEVA stock, worth $486 Million. This represents 15.49% of its overall portfolio holdings.
Number of Shares
26,462,600
Previous 26,424,535
0.14%
Holding current value
$486 Million
Previous $373 Million
15.33%
% of portfolio
15.49%
Previous 16.76%
Shares
8 transactions
Others Institutions Holding TEVA
# of Institutions
603Shares Held
567MCall Options Held
25.2MPut Options Held
5.08M-
Black Rock Inc. New York, NY43MShares$790 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.3MShares$668 Million41.14% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L332.3MShares$594 Million5.5% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.29.1MShares$535 Million7.9% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$530 Million3.23% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $20.4B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...